- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Lenalidomide – March 2013
Lenalidomide, capsules, 5 mg and 10 mg, Revlimid®
Last updated
8 November 2023